[Molecular targetting therapy for non-small-cell lung neoplasms with EGF-R inhibitors]

Nihon Naika Gakkai Zasshi. 2003 Feb 10;92(2):318-23.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Carcinoma, Small Cell / drug therapy*
  • Carcinoma, Small Cell / metabolism
  • Cetuximab
  • Clinical Trials as Topic
  • Depression, Chemical
  • ErbB Receptors / antagonists & inhibitors*
  • ErbB Receptors / metabolism
  • Erlotinib Hydrochloride
  • Gefitinib
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / metabolism
  • Phosphorylation / drug effects
  • Quinazolines / pharmacology*
  • Quinazolines / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Quinazolines
  • Erlotinib Hydrochloride
  • ErbB Receptors
  • Cetuximab
  • Gefitinib